A detailed history of Northern Trust Corp transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 2,357,679 shares of PACB stock, worth $4.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,357,679
Previous 2,504,276 5.85%
Holding current value
$4.6 Million
Previous $3.43 Million 16.85%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$1.2 - $2.17 $175,916 - $318,115
-146,597 Reduced 5.85%
2,357,679 $4.01 Million
Q2 2024

Aug 14, 2024

SELL
$1.36 - $3.65 $52,524 - $140,966
-38,621 Reduced 1.52%
2,504,276 $3.43 Million
Q1 2024

May 14, 2024

SELL
$3.52 - $9.59 $544,881 - $1.48 Million
-154,796 Reduced 5.74%
2,542,897 $9.54 Million
Q4 2023

Feb 13, 2024

SELL
$5.97 - $10.36 $722,799 - $1.25 Million
-121,072 Reduced 4.3%
2,697,693 $26.5 Million
Q3 2023

Nov 13, 2023

BUY
$8.23 - $13.93 $24,722 - $41,845
3,004 Added 0.11%
2,818,765 $23.5 Million
Q2 2023

Aug 11, 2023

BUY
$9.97 - $14.05 $2.76 Million - $3.89 Million
276,619 Added 10.89%
2,815,761 $37.4 Million
Q1 2023

May 15, 2023

BUY
$7.94 - $12.02 $1.12 Million - $1.69 Million
140,999 Added 5.88%
2,539,142 $29.4 Million
Q4 2022

Feb 13, 2023

SELL
$5.67 - $11.2 $90,340 - $178,449
-15,933 Reduced 0.66%
2,398,143 $19.6 Million
Q3 2022

Nov 14, 2022

BUY
$3.93 - $8.57 $1.16 Million - $2.53 Million
294,991 Added 13.92%
2,414,076 $14 Million
Q2 2022

Aug 12, 2022

BUY
$4.02 - $10.43 $560,054 - $1.45 Million
139,317 Added 7.04%
2,119,085 $9.37 Million
Q1 2022

May 13, 2022

SELL
$8.43 - $20.9 $35,321 - $87,571
-4,190 Reduced 0.21%
1,979,768 $18 Million
Q4 2021

Feb 08, 2022

SELL
$19.26 - $30.08 $6.14 Million - $9.58 Million
-318,587 Reduced 13.84%
1,983,958 $40.6 Million
Q3 2021

Nov 15, 2021

SELL
$24.86 - $35.02 $1.1 Million - $1.56 Million
-44,413 Reduced 1.89%
2,302,545 $58.8 Million
Q2 2021

Aug 13, 2021

BUY
$22.3 - $36.02 $6.21 Million - $10 Million
278,659 Added 13.47%
2,346,958 $82.1 Million
Q1 2021

May 12, 2021

SELL
$26.38 - $51.15 $1.47 Million - $2.86 Million
-55,839 Reduced 2.63%
2,068,299 $68.9 Million
Q4 2020

Feb 11, 2021

BUY
$10.5 - $28.5 $518,038 - $1.41 Million
49,337 Added 2.38%
2,124,138 $55.1 Million
Q3 2020

Nov 16, 2020

BUY
$3.61 - $9.87 $594,296 - $1.62 Million
164,625 Added 8.62%
2,074,801 $20.5 Million
Q2 2020

Aug 14, 2020

BUY
$2.65 - $4.03 $287,183 - $436,735
108,371 Added 6.01%
1,910,176 $6.59 Million
Q1 2020

May 14, 2020

BUY
$2.36 - $5.26 $64,177 - $143,040
27,194 Added 1.53%
1,801,805 $5.51 Million
Q4 2019

Feb 14, 2020

SELL
$4.6 - $5.57 $257,659 - $311,992
-56,013 Reduced 3.06%
1,774,611 $9.12 Million
Q3 2019

Nov 13, 2019

BUY
$4.99 - $6.16 $369,404 - $456,018
74,029 Added 4.21%
1,830,624 $9.45 Million
Q2 2019

Aug 13, 2019

BUY
$5.92 - $7.41 $78,676 - $98,478
13,290 Added 0.76%
1,756,595 $10.6 Million
Q1 2019

May 13, 2019

BUY
$6.8 - $7.4 $379,283 - $412,749
55,777 Added 3.31%
1,743,305 $12.6 Million
Q4 2018

Feb 12, 2019

BUY
$3.99 - $7.82 $643,219 - $1.26 Million
161,208 Added 10.56%
1,687,528 $12.5 Million
Q3 2018

Nov 14, 2018

BUY
$3.52 - $5.55 $222,076 - $350,149
63,090 Added 4.31%
1,526,320 $8.26 Million
Q2 2018

Sep 18, 2018

SELL
$2.11 - $3.92 $17,076 - $31,724
-8,093 Reduced 0.55%
1,463,230 $5.2 Million
Q2 2018

Aug 14, 2018

BUY
$2.11 - $3.92 $312,666 - $580,877
148,183 Added 11.2%
1,471,323 $5.22 Million
Q1 2018

May 09, 2018

BUY
$2.05 - $3.23 $242,338 - $381,831
118,214 Added 9.81%
1,323,140 $2.71 Million
Q4 2017

Feb 14, 2018

SELL
$2.59 - $5.44 $147,705 - $310,237
-57,029 Reduced 4.52%
1,204,926 $3.18 Million
Q3 2017

Nov 13, 2017

BUY
$3.2 - $5.57 $4.04 Million - $7.03 Million
1,261,955
1,261,955 $6.63 Million

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.